The Clorox Company (NYSE:CLX) Shares Acquired by Anchor Investment Management LLC

Anchor Investment Management LLC boosted its holdings in The Clorox Company (NYSE:CLX) by 3.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,497 shares of the company’s stock after buying an additional 309 shares during the quarter. Anchor Investment Management LLC’s holdings in Clorox were worth $1,705,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CLX. Norges Bank acquired a new position in shares of Clorox in the fourth quarter worth about $259,041,000. FMR LLC boosted its stake in Clorox by 75.4% in the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock worth $221,163,000 after purchasing an additional 585,526 shares during the period. ExodusPoint Capital Management LP grew its position in Clorox by 187.9% during the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after purchasing an additional 456,114 shares in the last quarter. Amundi raised its stake in Clorox by 42.6% during the 4th quarter. Amundi now owns 1,032,283 shares of the company’s stock valued at $165,816,000 after purchasing an additional 308,234 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Clorox by 302.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after purchasing an additional 265,455 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $139.48 on Wednesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market capitalization of $17.18 billion, a P/E ratio of 38.11, a P/E/G ratio of 2.62 and a beta of 0.61. The business has a 50-day moving average of $147.13 and a two-hundred day moving average of $156.93. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company posted $2.16 earnings per share. On average, equities research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.50%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CLX. Evercore ISI lifted their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Citigroup reduced their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research report on Monday. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating on the stock in a research report on Friday, April 11th. Finally, Wells Fargo & Company cut their target price on shares of Clorox from $161.00 to $155.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and an average price target of $155.08.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.